Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression
New England Journal of Medicine · 05.10.2023 · 389 (14) · 1298-1309
DOI: 10.1056/nejmoa2304145 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 05.10.2023. Verfasst von Andreas Reif und 16 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Psychiatry, Psychosomatic Medicine, and Psychotherapy, University Hospital, Goethe University Frankfurt, and Fraunhofer Instit…. Hauptthemen laut MEDLINE: Antidepressive Agents, Quetiapine Fumarate, Selective Serotonin Reuptake Inhibitors, Serotonin and Noradrenaline Reuptake Inhibitors. Die Arbeit wurde bisher 233-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Janssen EMEA.
Themen: Depression
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Department of Psychiatry, Psychosomatic Medicine, and Psychotherapy, University Hospital, Goethe University Frankfurt, and Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt (A.R.)…
ORCID-Profile: Andreas Reif, Tetsuro Ito, Albino J Oliveira-Maia
Förderung
- Janssen EMEA
Zitieren
APA
Reif, A., Bitter, I., Buyze, J., Cebulla, K., Frey, R., Fu, D. J., Ito, T., Kambarov, Y., Llorca, P. M., Oliveira-Maia, A. J., Messer, T., Mulhern-Haughey, S., Rive, B., von Holt, C., Young, A. H., Godinov, Y., & ESCAPE-TRD Investigators (2023). Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression. New England Journal of Medicine, 389(14), 1298-1309. https://doi.org/10.1056/nejmoa2304145
Vancouver
Reif A, Bitter I, Buyze J, Cebulla K, Frey R, Fu DJ, et al. Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression. New England Journal of Medicine. 2023;389(14):1298-1309. doi:10.1056/nejmoa2304145
BibTeX
@article{Reif2023,
author = {Reif, Andreas and Bitter, Istvan and Buyze, Jozefien and Cebulla, Kerstin and Frey, Richard and Fu, Dong-Jing and Ito, Tetsuro and Kambarov, Yerkebulan and Llorca, Pierre-Michel and Oliveira-Maia, Albino J and Messer, Thomas and Mulhern-Haughey, Siobhán and Rive, Benoît and von Holt, Christian and Young, Allan H and Godinov, Yordan and ESCAPE-TRD Investigators, ESCAPE-TRD Investigators},
title = {Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression},
journal = {New England Journal of Medicine},
year = {2023},
volume = {389},
number = {14},
pages = {1298--1309},
doi = {10.1056/nejmoa2304145}
}
EUVIMED